Waving the white flag? Medtronic partners with Abbott for CGM.
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
Medtronic
New technologies for MDI. Have Roche and Medtronic missed a trick?
At ATTD, we saw the Medtronic Experience (which sounds like a bad rock tribute band) and Roche’s SmartGuide describing themselves as the next great thing […]
Medtronic Simplera. Is it really the “Simple Era”?
At ATTD in Florence, Medtronic were giving away their new CGM, Simplera, to those who wanted to try them out in their experience booth, and […]
How far are we from fully closed loop? News from ATTD 2023
One of the great things about the ATTD conference is the updates on the technologies that are upcoming, alongside the “What’s already there”. It’s very […]
Tidepool Loop. Approved but not yet available
With the recent news that Tidepool’s Loop has been approved by the FDA, the detail, that there are no pumps available that work with it, […]
Control:IQ vs 670G – Which is better? The pivotal trial results are in.
With news that the Tandem T:Slim X2 Control:IQ pivotal study results have been published, I thought it would be worth comparing the data to that […]
Inside the Medtronic recall. What should we make of it?
As most people involved in WeAreNotWaiting are aware, on June 27th, the FDA issued a warning about cybersecurity issues with older medtronic pumps. These happen […]
Comparing Tandem’s Basal-IQ to Medtronic’s SmartGuard. Which Predictive Low Glucose Suspend is best?
If you’ve been looking at Diabetes technology recently, it’s hard not to have seen the recent news from Tandem about rolling out their Predictive Low […]
The real cost of Time in Range – what it takes to replace Hba1C #ATTD2018
Anyone watching the Twitter feed for the Advanced Technologies and Treatments for Diabetes 2018 conference can’t fail to have noticed that, once again, the answer […]